Promoted Content
Promoted Content

Looking for Hypromellose pharmaceutical excipients? Find information on Hypromellose's applications, manufacturers, suppliers, etc. on PharmaCompass.

Client Email Product
Hypromellose
  • DESCRIPTION

PharmaCompass
Previous
Next
  • DESCRIPTION

https://www.pharmacompass.com/pdf-document/pubchem/hypromellose-who-1482576128.pdf

  • WHO-GMP
Applications: Direct compression for modified release dosage forms
Dosage Form: Capsule, Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Ethylcellulose , Hydroxypropyl methyl cellulose K4M, Hydroxypropyl Cellulose, Colloidal Silicon Dioxide, Maize Starch, Magnesium Stearate and Talc
  • FDA
  • EDQM
Applications: It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.
Dosage Form: Capsule
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Complies with relevant European, Japanese and US Pharmacopeia monographs
Technical Specifications: Water content – less than 6%; Size #0
  • FDA
Applications: Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Dosage Form: Capsule, Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Capsule, Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Direct compression for modified release dosage forms
Dosage Form: Capsule, Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Microcrystalline Cellulose, Ethylcellulose, Hydroxypropyl methyl cellulose K100Microcrystalline Cellulose, Ethylcellulose, Hydroxypropyl methyl cellulose K100M, Hydroxypropyl Cellulose, Colloidal Silicon Dioxide and Magnesium StearateM, Hydroxypropyl Cell
  • FDA
Applications: Sustained Release Tablet Matrix
Dosage Form: Capsule, Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available
  • FDA
Applications: Immediate Release
Dosage Form: Tablet
More Info on Category: Controlled & Modified Release
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements
Technical Specifications: Not Available